- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Low Leverage High Rewards
Hong Kong Pharmaceuticals & Biotech Low Leverage High Rewards
Results
11
11 companies
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.2b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$8.60
7D
2.0%
1Y
2.7%
Tong Ren Tang Technologies
Market Cap: HK$5.5b
Produces and distributes Chinese medicine products in Mainland China and Hong Kong.
1666
HK$4.29
7D
3.4%
1Y
-9.9%
Consun Pharmaceutical Group
Market Cap: HK$15.0b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$17.79
7D
7.3%
1Y
119.4%
Essex Bio-Technology
Market Cap: HK$2.3b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.02
7D
0.5%
1Y
45.7%
Shandong Xinhua Pharmaceutical
Market Cap: HK$10.1b
Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.
719
HK$6.71
7D
1.4%
1Y
16.9%
CSPC Pharmaceutical Group
Market Cap: HK$103.6b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$9.06
7D
0.8%
1Y
90.3%
Shanghai Haohai Biological Technology
Market Cap: HK$10.0b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$24.26
7D
0.9%
1Y
-9.3%
China Shineway Pharmaceutical Group
Market Cap: HK$7.0b
An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
2877
HK$9.21
7D
3.0%
1Y
5.9%
Jacobson Pharma
Market Cap: HK$2.5b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.26
7D
0%
1Y
5.0%
Pak Fah Yeow International
Market Cap: HK$719.9m
An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.
239
HK$2.31
7D
-0.9%
1Y
4.5%
Dawnrays Pharmaceutical (Holdings)
Market Cap: HK$1.7b
An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.
2348
HK$1.15
7D
-0.9%
1Y
-5.0%